ACCESSION: MSBNK-SMB_Measured-HSA015P0112006
RECORD_TITLE: Annotated; Cytosine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 29
COMMENT: RAW_SPEC {'EL03_pos_1331': {'bp': 966154.0, 'sum': 2621931.0}, 'EL03_pos_1659': {'bp': 881575.0, 'sum': 2623429.0}, 'EL20_pos_1262': {'bp': 464112.0, 'sum': 1663890.0}, 'EL19_pos_1275': {'bp': 459710.0, 'sum': 1840354.0}, 'EL02_pos_1268': {'bp': 448076.0, 'sum': 1842147.0}, 'EL05_pos_1282': {'bp': 446288.0, 'sum': 1570390.0}, 'EL17_pos_1262': {'bp': 430688.0, 'sum': 1632877.0}, 'EL06_pos_1269': {'bp': 429872.0, 'sum': 1610841.0}, 'EL18_pos_1258': {'bp': 418559.0, 'sum': 1709743.0}, 'EL16_pos_1263': {'bp': 418414.0, 'sum': 1557330.0}, 'EL09_pos_1283': {'bp': 417665.0, 'sum': 1336088.0}, 'EL08_pos_1269': {'bp': 416148.0, 'sum': 1438473.0}, 'EL14_pos_1661': {'bp': 412690.0, 'sum': 1437645.0}, 'EL04_pos_1282': {'bp': 411799.0, 'sum': 1369223.0}, 'EL24_pos_1283': {'bp': 411781.0, 'sum': 1363363.0}, 'EL19_pos_1660': {'bp': 408101.0, 'sum': 1523503.0}, 'EL01_pos_1265': {'bp': 407917.0, 'sum': 1524469.0}, 'EL17_pos_1648': {'bp': 406635.0, 'sum': 1540438.0}, 'EL15_pos_1269': {'bp': 403661.0, 'sum': 1517325.0}, 'EL21_pos_1274': {'bp': 403560.0, 'sum': 1508373.0}, 'EL23_pos_1275': {'bp': 402690.0, 'sum': 1398178.0}, 'EL13_pos_1263': {'bp': 400596.0, 'sum': 1568841.0}, 'EL16_pos_1665': {'bp': 387231.0, 'sum': 1291101.0}, 'EL04_pos_1514': {'bp': 377085.0, 'sum': 1608609.0}, 'EL13_pos_1664': {'bp': 376658.0, 'sum': 1284616.0}, 'EL18_pos_1655': {'bp': 375414.0, 'sum': 1436343.0}, 'EL21_pos_1658': {'bp': 373136.0, 'sum': 1323446.0}, 'EL14_pos_1269': {'bp': 370073.0, 'sum': 1581662.0}, 'EL08_pos_1661': {'bp': 359391.0, 'sum': 1274470.0}}
COMMENT: RETENTION_TIME_STDEV 0.293
COMMENT: PRECURSOR_M/Z_RAW 112.050939
COMMENT: PRECURSOR_M/Z_STDEV 0.000051
COMMENT: PRECURSOR_IN_MS1 mz 112.050505; int 69.022; delta(ppm) 0.654385
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.279; C4H5N3O; [M+H]+; delta(ppm) -0.279171
COMMENT: PROPOSED_MF MS-FINDER 3.568; C4H5N3O; [M+H]+; delta(ppm) -0.278763
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.375; C4H5N3O; [M+H]+; delta(ppm) -0.278763
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H5N3O; [M+H]+; delta(ppm) -0.278763
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.959; C4H5N3O; [M+H]+; delta(ppm) -0.278763
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.532; CH6FN3O2; [M+H]+; delta(ppm) -10.476322
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.415; C6H7O2; [M+H]+; delta(ppm) -12.261277
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.399; H8N4OP; [M+H]+; delta(ppm) -3.037359
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.177; C2H3N6; [M+H]+; delta(ppm) 11.704038
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.737; C4H6F3; [M+H]+; delta(ppm) 9.561643
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.995; C4H5N3O; [M+H]+; delta(ppm) -0.278763
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.005; CH6FN3O2; [M+H]+; delta(ppm) -10.476322
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 31.000; OPTASPLRGRRNAP-UHFFFAOYSA-N; C4H5N3O; CYTOSINE
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.475; ZBNZAJFNDPPMDT-UHFFFAOYSA-N; [M+H]+; NC(=O)C1=CNC=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.325; BNYCHCAYYYRJSH-UHFFFAOYSA-N; [M+H]+; C1=C(NN=C1)C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.216; NMIZONYLXCOHEF-UHFFFAOYSA-N; [M+H]+; C1=CN=C(N1)C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.107; DVLHGMFTRAFHPR-UHFFFAOYSA-N; [M+H]+; C1=CN(N=C1)C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.071; BIXBBIPTYBJTRY-UHFFFAOYSA-N; [M+H]+; NC1=NC(=O)N2CC12
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.262; OPTASPLRGRRNAP-UHFFFAOYSA-N; [M+H]+; Cytosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.950; XQCZBXHVTFVIFE-UHFFFAOYSA-N; [M+H]+; 2-amino-4-hydroxypyrimidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.664; FVWKFDRZDTWXGT-UHFFFAOYSA-N; [M+H]+; 5-diazenyl-1H-pyrrol-2-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.400; ZBNZAJFNDPPMDT-UHFFFAOYSA-N; [M+H]+; UNPD207467
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.374; BIXBBIPTYBJTRY-UHFFFAOYSA-N; [M+H]+; Imexon
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.359; BNYCHCAYYYRJSH-UHFFFAOYSA-N; [M+H]+; 1H-pyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.342; DVLHGMFTRAFHPR-UHFFFAOYSA-N; [M+H]+; pyrazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.342; KQLHRXQKORXSTC-UHFFFAOYSA-N; [M+H]+; 3-amino-1H-pyrazin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.322; QBKIGBNGDYTHNG-UHFFFAOYSA-N; [M+H]+; 4-amino-1,3-diazabicyclo[3.1.0]hex-4-en-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.307; SMXZQOMVCREYNY-UHFFFAOYSA-N; [M+H]+; N-(1H-imidazol-2-yl)formamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.296; NMIZONYLXCOHEF-UHFFFAOYSA-N; [M+H]+; 1H-imidazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.255; NCMONXLWVRSCBP-UHFFFAOYSA-N; [M+H]+; 2-methoxy-1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.203; PRFAXWWHJWIUPI-UHFFFAOYSA-N; [M+H]+; 4-methoxytriazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; QBKIGBNGDYTHNG-UHFFFAOYSA-N; [M+H]+; 4-amino-1,3-diazabicyclo[3.1.0]hex-4-en-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.998; BNYCHCAYYYRJSH-UHFFFAOYSA-N; [M+H]+; 1H-pyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.998; NMIZONYLXCOHEF-UHFFFAOYSA-N; [M+H]+; 1H-imidazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.971; KQLHRXQKORXSTC-UHFFFAOYSA-N; [M+H]+; 3-amino-1H-pyrazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.847; FVWKFDRZDTWXGT-UHFFFAOYSA-N; [M+H]+; 5-diazenyl-1H-pyrrol-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.841; DVLHGMFTRAFHPR-UHFFFAOYSA-N; [M+H]+; pyrazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.833; ZBNZAJFNDPPMDT-UHFFFAOYSA-N; [M+H]+; UNPD207467
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.811; OPTASPLRGRRNAP-UHFFFAOYSA-N; [M+H]+; Cytosine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.810; BIXBBIPTYBJTRY-UHFFFAOYSA-N; [M+H]+; Imexon
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.807; XQCZBXHVTFVIFE-UHFFFAOYSA-N; [M+H]+; 2-amino-4-hydroxypyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.722; SMXZQOMVCREYNY-UHFFFAOYSA-N; [M+H]+; N-(1H-imidazol-2-yl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.099; PRFAXWWHJWIUPI-UHFFFAOYSA-N; [M+H]+; 4-methoxytriazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.087; NCMONXLWVRSCBP-UHFFFAOYSA-N; [M+H]+; 2-methoxy-1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.804; OPTASPLRGRRNAP-UHFFFAOYSA-N; [M+H]+; 6-amino-1H-pyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.767; XQCZBXHVTFVIFE-UHFFFAOYSA-N; [M+H]+; 2-amino-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.428; BNYCHCAYYYRJSH-UHFFFAOYSA-N; [M+H]+; 1H-pyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.163; ZVXKYWHJBYIYNI-UHFFFAOYSA-N; [M+H]+; 1H-pyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.135; VROMXVIODDASTK-UHFFFAOYSA-N; [M+H]+; 5-amino-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; HFMLLTVIMFEQRE-UHFFFAOYSA-N; [M+H]+; 4-amino-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; XWLBYEBHQNSCKA-UHFFFAOYSA-N; [M+H]+; 5-amino-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.127; MJSOXUAUMZKRAK-UHFFFAOYSA-N; [M+H]+; 4-amino-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; BIXBBIPTYBJTRY-UHFFFAOYSA-N; [M+H]+; 4-amino-1,3-diazabicyclo[3.1.0]hex-3-en-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.088; JWYFWQDQLAEMAF-UHFFFAOYSA-N; [M+H]+; 6-amino-1H-pyrazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; RMSRKYVNQYEPHO-UHFFFAOYSA-N; [M+H]+; 2-cyanoaziridine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.060; ZBNZAJFNDPPMDT-UHFFFAOYSA-N; [M+H]+; 1H-imidazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; VTYNJTABFCXTBH-UHFFFAOYSA-N; [M+H]+; 1,2-oxazole-3-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.996; MMZLICVOTDAZOX-UHFFFAOYSA-N; [M+H]+; 3-amino-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.911; NVYMOVCPYONOSF-UHFFFAOYSA-N; [M+H]+; 2-aminopyrimidin-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.897; QPISWILGPJGWLV-UHFFFAOYSA-N; [M+H]+; 4-aminopyrimidin-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.892; CWNBIZNFVWOUFW-UHFFFAOYSA-N; [M+H]+; 5-amino-1H-pyrazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.852; SMXZQOMVCREYNY-UHFFFAOYSA-N; [M+H]+; N-(1H-imidazol-2-yl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; JFSBTWPIEZSDPR-UHFFFAOYSA-N; [M+H]+; 5-methyl-2H-triazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.732; TXNWXXKJPZYOKA-UHFFFAOYSA-N; [M+H]+; 5-methyl-1H-1,2,4-triazole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.720; GYKQWOBXJHLLAP-UHFFFAOYSA-N; [M+H]+; 1-(1H-1,2,4-triazol-5-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.436; FRJSHBUKQSGJNG-UHFFFAOYSA-N; [M+H]+; 1-methyltriazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.434; VFAQDMYUCHBIJL-UHFFFAOYSA-N; [M+H]+; 3-methyltriazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.432; BJDKLXOVGAGGHJ-UHFFFAOYSA-N; [M+H]+; 4-ethenyl-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.424; PDWZJMKDSKSWMD-UHFFFAOYSA-N; [M+H]+; 6-methyl-4H-1,2,4-triazin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.421; YWHCWSOBIXRMBY-UHFFFAOYSA-N; [M+H]+; 4-methyl-1,2,4-triazole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.359; OJBNZAZUTPLWDT-UHFFFAOYSA-N; [M+H]+; 2-methyl-1,2,4-triazole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.357; NLBSACQGJDXXNQ-UHFFFAOYSA-N; [M+H]+; 1-methyl-1,2,4-triazole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.354; ADIHVKJNUPTHMC-UHFFFAOYSA-N; [M+H]+; 2-methyltriazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -10.886; OPTASPLRGRRNAP; [M+H]+; cytosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -84.199; XQCZBXHVTFVIFE; [M+H]+; zlchem 273
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -96.728; HFMLLTVIMFEQRE; [M+H]+; zlchem 81
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -115.136; XWLBYEBHQNSCKA; [M+H]+; 5-aminopyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.119; NMIZONYLXCOHEF; [M+H]+; Imidazolcarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -145.706; NVYMOVCPYONOSF; [M+H]+; zlchem 1241
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -151.688; ZBNZAJFNDPPMDT; [M+H]+; Imidazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -164.947; NCMONXLWVRSCBP; [M+H]+; 2-methoxy-1,3,5-triazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -177.486; BNYCHCAYYYRJSH; [M+H]+; Pyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.771; PDWZJMKDSKSWMD; [M+H]+; 6-methyl-1,2,4-triazin-5-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.339; FRJSHBUKQSGJNG; [M+H]+; 1-methyl-1H-1,2,3-triazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -203.724; BJDKLXOVGAGGHJ; [M+H]+; 4-Vinyl-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.654; NLBSACQGJDXXNQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.019; OJBNZAZUTPLWDT; [M+H]+; 1-methyl-1H-1,2,4-triazole-5-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.846; DQGMASZUGMDEFA; [M+H]+; 1-Methyl-2-nitrosoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.781; YWHCWSOBIXRMBY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.703; RMSRKYVNQYEPHO; [M+H]+; N-(2-Cyanoethylene)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.050; BIXBBIPTYBJTRY; [M+H]+; Imexonum
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.820; OPTASPLRGRRNAP; [M+H]+; cytosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -20.027; OPTASPLRGRRNAP; [M+H]+; Zytosin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -42.175; XQCZBXHVTFVIFE; [M+H]+; 2-amino-1,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -55.530; JWYFWQDQLAEMAF; [M+H]+; 6-Aminopyrazin-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -59.904; KQLHRXQKORXSTC; [M+H]+; 3-Aminopyrazin-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -64.311; XWLBYEBHQNSCKA; [M+H]+; 5-Amino-4-hydroxypyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -66.212; MJSOXUAUMZKRAK; [M+H]+; 5-Aminopyridazin-3(2h)-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -66.470; HFMLLTVIMFEQRE; [M+H]+; 4-Amino-6-hydroxypyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -68.275; NMIZONYLXCOHEF; [M+H]+; 1H-Imidazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -73.587; ZVXKYWHJBYIYNI; [M+H]+; 1H-pyrazol-2-ium-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -77.186; PDWZJMKDSKSWMD; [M+H]+; 6-Methyl-1,2,4-triazin-5-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.784; OPTASPLRGRRNAP; [M+H]+; Zytosin
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Cytosine, OPTASPLRGRRNAP-UHFFFAOYSA-N; Matching to 31 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (7), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000630;
CH$NAME: Cytosine
CH$NAME: 6-amino-1H-pyrimidin-2-one
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C4H5N3O
CH$EXACT_MASS: 111.043262
CH$SMILES: C1=C(NC(=O)N=C1)N
CH$IUPAC: InChI=1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8)
CH$LINK: CHEBI CHEBI:16040
CH$LINK: HMDB HMDB0000630
CH$LINK: INCHIKEY OPTASPLRGRRNAP-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:597
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.250
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 112.050507
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-5900000000-cc1ac1bd2cf7f783f91c
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0181240 26.6312 55.018832 0.7270 4.02 0.3300 25 f{C3H3O1}/5.14ppm,p-C1H3N3
  55.0545050 66.9385 55.055213 0.4904 11.11 0.1377 25 ?
  67.0543916 74.0834 67.055133 0.4921 8.32 0.2675 29 ?
  68.0496269 32.1627 68.050369 0.8670 4.85 0.3153 29 f{C4H6N1}/2.22ppm,p-N2O1
  69.0336377 120.5049 69.034381 0.4201 16.12 0.0236 29 f{C4H5O1}/2.12ppm,p-H1N3
  69.0448308 36.9689 69.045574 0.9559 12.72 0.9557 29 f{C3H5N2}/1.54ppm,p-C1H1N1O1
  69.0700146 120.9358 69.070758 0.4199 8.22 0.2576 29 ?
  70.0288972 18.4266 70.029640 1.6136 7.00 0.1583 24 f{C3H4N1O1}/2.24ppm,p-C1H2N2
  70.0652803 25.6099 70.066024 1.0990 5.62 0.5308 25 ?
  71.0857913 8.8995 71.086534 0.9707 1.54 0.4365 22 ?
  72.0809403 13.5171 72.081683 1.7342 9.75 0.2727 22 ?
  72.9372319 92.5347 72.937974 0.4662 32.05 -0.3213 28 ?
  79.0542899 147.5616 79.055022 0.4174 8.80 0.3936 29 ?
  80.9451040 29.4095 80.945831 1.1119 10.61 0.2269 25 ?
  83.0855962 20.7617 83.086316 1.3841 6.02 -0.1700 25 ?
  90.9477376 18.9628 90.948418 1.3194 5.94 -0.4423 25 ?
  93.0700177 11.3245 93.070684 1.2034 2.15 0.1662 25 ?
  94.0400768 15.5599 94.040737 0.8401 5.35 0.8848 22 f{C4H4N3}/1.10ppm,p-H2O1
  94.0651944 14.7697 94.065854 1.1481 2.77 0.1303 26 ?
  95.0239871 113.4437 95.024640 0.4630 33.39 0.9635 29 f{C4H3N2O1}/-0.02ppm,p-H3N1
  95.0491616 25.1066 95.049814 1.3572 4.67 0.0411 28 ?
  96.0080755 7.1938 96.008721 1.0728 2.13 0.3078 21 ?
  96.0807803 96.5037 96.081425 0.3955 5.81 0.0507 29 ?
  97.0647599 32.2899 97.065397 0.9066 3.20 0.3125 28 ?
  110.0601244 26.2477 110.060646 1.1267 11.05 0.3046 26 ?
  111.0441126 31.2761 111.044627 0.9996 5.60 0.2498 29 ?
  111.0553680 23.6285 111.055882 1.2516 17.00 0.0936 28 ?
  111.0804779 23.5716 111.080992 1.1073 4.08 0.2228 27 ?
  112.0505785 463.3251 112.051085 0.3659 139.77 1.0000 29 f{C4H6N3O1}/0.36ppm,p
  112.0757046 47.8956 112.076211 0.7406 7.41 0.1217 29 ?
  112.1121322 20.9573 112.112639 0.9633 5.31 -0.1096 24 ?
  112.9998449 98.6915 113.000345 0.5487 65.45 0.4455 26 ?
  113.0233343 46.8086 113.023834 0.6990 7.52 0.3734 29 ?
  113.0346498 30.6460 113.035149 0.9555 8.12 0.3566 26 ?
  113.0599524 118.9222 113.060452 0.7076 15.32 0.2277 25 ?
  113.1073253 21.6667 113.107824 1.1051 20.14 0.2179 27 ?
  114.0913538 999.0000 114.091845 0.3418 0.00 0.2739 29 ?
  116.9662058 36.7086 116.966673 1.1029 13.52 0.0379 27 ?
  130.9818256 33.6742 130.982149 1.2750 12.74 -0.0159 27 ?
PK$NUM_PEAK: 39
PK$PEAK: m/z int. rel.int.
  55.018124 26.63 26
  55.054505 66.94 66
  67.054392 74.08 74
  68.049627 32.16 32
  69.033638 120.50 120
  69.044831 36.97 36
  69.070015 120.94 120
  70.028897 18.43 18
  70.065280 25.61 25
  71.085791 8.90 8
  72.080940 13.52 13
  72.937232 92.53 92
  79.054290 147.56 147
  80.945104 29.41 29
  83.085596 20.76 20
  90.947738 18.96 18
  93.070018 11.32 11
  94.040077 15.56 15
  94.065194 14.77 14
  95.023987 113.44 113
  95.049162 25.11 25
  96.008076 7.19 7
  96.080780 96.50 96
  97.064760 32.29 32
  110.060124 26.25 26
  111.044113 31.28 31
  111.055368 23.63 23
  111.080478 23.57 23
  112.050578 463.33 463
  112.075705 47.90 47
  112.112132 20.96 20
  112.999845 98.69 98
  113.023334 46.81 46
  113.034650 30.65 30
  113.059952 118.92 118
  113.107325 21.67 21
  114.091354 999.00 999
  116.966206 36.71 36
  130.981826 33.67 33
//
